PNC FINANCIAL SERVICES GROUP, INC. - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 172 filers reported holding ACCELERON PHARMA INC in Q3 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$1,188,000
+36.6%
6,911
-0.3%
0.00%0.0%
Q2 2021$870,000
-14.7%
6,934
-7.8%
0.00%0.0%
Q1 2021$1,020,000
+4.2%
7,521
-1.6%
0.00%0.0%
Q4 2020$979,000
+11.0%
7,644
-2.5%
0.00%0.0%
Q3 2020$882,000
+42.7%
7,840
+20.9%
0.00%0.0%
Q2 2020$618,000
+12.2%
6,486
+5.8%
0.00%0.0%
Q1 2020$551,000
+20.3%
6,131
-28.9%
0.00%
Q4 2019$458,000
+46.3%
8,618
+9.3%
0.00%
Q3 2019$313,000
-0.3%
7,886
+3.1%
0.00%
Q2 2019$314,000
-7.4%
7,646
+5.0%
0.00%
Q1 2019$339,000
+5.0%
7,280
-2.2%
0.00%
Q4 2018$323,000
-5.8%
7,440
+24.4%
0.00%
Q3 2018$343,000
+61.0%
5,980
+36.4%
0.00%
Q2 2018$213,000
-95.8%
4,384
-96.7%
0.00%
-100.0%
Q1 2018$5,127,000
+1373.3%
131,119
+1496.7%
0.01%
Q4 2017$348,000
+15.2%
8,212
+1.6%
0.00%
Q3 2017$302,000
+17.1%
8,080
-4.5%
0.00%
Q2 2017$258,000
+81.7%
8,460
+57.8%
0.00%
Q1 2017$142,000
-2.7%
5,360
-6.9%
0.00%
Q4 2016$146,000
-19.8%
5,760
+14.7%
0.00%
Q3 2016$182,000
+5.8%
5,020
-0.7%
0.00%
Q2 2016$172,000
+5633.3%
5,055
+4112.5%
0.00%
Q1 2016$3,000
-50.0%
120
+3.4%
0.00%
Q4 2015$6,000
+100.0%
1160.0%0.00%
Q3 2015$3,000
-25.0%
116
+3.6%
0.00%
Q2 2015$4,000
+100.0%
112
+83.6%
0.00%
Q1 2015$2,000610.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 42,030$3,777,0006.01%
Artal Group S.A. 1,500,000$134,805,0005.70%
GREAT POINT PARTNERS LLC 535,627$48,137,0005.03%
KINGDON CAPITAL MANAGEMENT, L.L.C. 211,038$18,966,0003.47%
Cormorant Asset Management, LP 825,000$74,143,0003.44%
Graticule Asia Macro Advisors LLC 48,700$4,377,0003.20%
Avoro Capital Advisors LLC 860,000$77,288,0002.61%
QVT Financial LP 120,264$10,808,0002.52%
Ikarian Capital, LLC 316,900$28,480,0002.14%
Avidity Partners Management LP 166,000$14,918,0002.06%
View complete list of ACCELERON PHARMA INC shareholders